GENIE
Celltheon Corporation
Application Filed: 2020-05-08
Trademark Application Details
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
| Website |
www.celltheon.com
 |
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88908028 |
| Mark Literal Elements | None |
| Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Standard Character Claim | No |
| Current Location | NEW APPLICATION PROCESSING 2020-05-18 |
| Basis | No |
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Docket Number | TM-05082020 |
Timeline
| 2020-05-08 | Application Filed |
| 2020-05-18 | Location: NEW APPLICATION PROCESSING |
| 2020-05-18 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
| 2020-05-20 | Location: NEW APPLICATION PROCESSING |
| 2020-05-20 | Status: Live/Pending |
| 2020-05-20 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CELLTHEON CORPORATION |
| Address | SUITE 826 32980 Alvarado Niles Rd Union City CA 94587 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
 Application | MULTI | 2020-05-08 |
 Drawing | JPEG | 2020-05-08 |
| Specimen | JPEG | 2020-05-08 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Gene Therapy Platform |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-05-20 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-08-04 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-08-09 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-08-09 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-08-09 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-01-15 | 6 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-04-30 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-05-05 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-05-05 | 9 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2021-06-02 | 10 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2021-06-02 | 11 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2021-06-02 | 12 GNFN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-06-14 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-06-14 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-06-14 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-06-14 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-06-14 | 17 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-06-30 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-07-20 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-07-20 | 20 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-09-14 | 21 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-14 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2022-02-14 | 23 EXT1 S: |
| EXTENSION 1 GRANTED | 2022-02-14 | 24 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-16 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-08-10 | 26 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-08-10 | 27 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-08-10 | 28 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-12 | 29 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-01-30 | 30 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2023-01-30 | 31 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2023-01-30 | 32 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-01 | 33 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-08-01 | 34 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-08-01 | 35 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-08-01 | 36 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-08-03 | 37 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-03-05 | 38 EEXT I:Incoming Correspondence |
| SOU EXTENSION 5 FILED | 2024-03-05 | 39 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2024-03-05 | 40 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-03-06 | 41 EXRA E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 